Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
65.48 USD | -0.12% | -2.21% | +18.75% |
Apr. 17 | Ani Pharmaceuticals Insider Sold Shares Worth $1,500,589, According to a Recent SEC Filing | MT |
Apr. 09 | ANI Pharmaceuticals, Inc. Announces the Launch of Baclofen Oral Suspension | CI |
Financials (USD)
Sales 2024 * | 534M | Sales 2025 * | 575M | Capitalization | 1.37B |
---|---|---|---|---|---|
Net income 2024 * | 22M | Net income 2025 * | 34M | EV / Sales 2024 * | 2.42 x |
Net cash position 2024 * | 80.28M | Net cash position 2025 * | 188M | EV / Sales 2025 * | 2.06 x |
P/E ratio 2024 * |
50.9
x | P/E ratio 2025 * |
31.9
x | Employees | 642 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 80.97% |
Latest transcript on ANI Pharmaceuticals, Inc.
1 day | -0.12% | ||
1 week | -2.21% | ||
Current month | -5.28% | ||
1 month | -0.79% | ||
3 months | +17.77% | ||
6 months | +12.20% | ||
Current year | +18.75% |
Managers | Title | Age | Since |
---|---|---|---|
Nikhil Lalwani
CEO | Chief Executive Officer | 46 | 20-09-07 |
Stephen Carey
DFI | Director of Finance/CFO | 53 | 16-05-05 |
Patrick Walsh
CHM | Chairman | 63 | 18-05-16 |
Members of the board | Title | Age | Since |
---|---|---|---|
Thomas Haughey
BRD | Director/Board Member | 60 | 18-04-30 |
Antonio Pera
BRD | Director/Board Member | 66 | 20-08-05 |
David Nash
BRD | Director/Board Member | 68 | 18-09-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.95% | 11 M€ | -6.03% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-17 | 65.48 | -0.12% | 123,206 |
24-04-16 | 65.56 | -1.12% | 99,004 |
24-04-15 | 66.3 | -0.87% | 111,916 |
24-04-12 | 66.88 | -1.81% | 94,984 |
24-04-11 | 68.11 | +1.72% | 136,646 |
Delayed Quote Nasdaq, April 17, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+18.75% | 1.37B | |
+28.79% | 676B | |
+24.25% | 554B | |
-7.64% | 349B | |
+15.00% | 318B | |
+5.99% | 291B | |
+3.40% | 210B | |
-0.45% | 204B | |
-10.31% | 194B | |
-11.71% | 144B |
- Stock Market
- Equities
- ANIP Stock